North and East London Commissioning Support Unit has published this notice through Delta eSourcing
| Notice Summary |
|---|
| Title: | Waltham Forest Anticoagulation Services |
| Notice type: | Additional Information / Corrigendum Notice |
| Authority: | North and East London Commissioning Support Unit |
| Nature of contract: | Services |
| Procedure: | Not applicable |
| Short Description: | Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 January 2018 – 31 December 2020, with the option to extend for up to a further two years. Annual contract value is £292,000 |
| Published: | 18/08/2017 16:19 |
View Full Notice
Section I: Contracting authority/entity (as stated in the original notice)
I.1) Name and addresses
NHS Waltham Forest Clinical Commissioning Group
Kirkdale House, 7 Kirkdale Road, London, E11 1HP, United Kingdom
Tel. +44 2036881543, Email: nelcsu.welcpod-procurement@nhs.net
Main Address: http://www.walthamforestccg.nhs.uk/, Address of the buyer profile: http://www.walthamforestccg.nhs.uk/
NUTS Code: UKI5
Section II: Object (as stated in the original notice)
II.1) Scope of the procurement
II.1.1) Title: Waltham Forest Anticoagulation Services Reference number: Not Provided
II.1.2) Main CPV code:
85100000 - Health services.
II.1.3) Type of contract: SERVICES
II.1.4) Short Description: Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 January 2018 – 31 December 2020, with the option to extend for up to a further two years. Annual contract value is £292,000
Section VI: Complementary information
V1.5) Date of dispatch of this notice: 18/08/2017
VI.6) Original notice reference:
Notice Reference: 2017 - 209721
Notice number in OJ S: Not Provided
Date of dispatch of the original notice: 04/08/2017
Section VII: Changes
VII.1) Information to be changed or added
VII.1.1) Reason for change: Modification of original information submitted by the contracting authority
VII.1.2) Text to be corrected in original notice No: 1
Section Number: II.1.4
Lot No: Not provided
Place of text to be modified: II.1.4
Instead of: Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 January 2018 – 31 December 2020, with the option to extend for up to a further two years. Annual contract value is £292,000
Read: Waltham Forest CCG is seeking to commission a primary care-led service model for the monitoring and management of anticoagulation patients. The service is required to be delivered from a minimum of five sites across the borough, with at least three of these sites being local pharmacies. Initially the service will be responsible for the management of approximately 1200 stable patients on warfarin; the CCG will seek to work jointly with the provider and secondary care to further develop the anticoagulation pathway over the life of the contract, which may include extending the service to the monitoring of other types of anticoagulants. The service includes the provision of Point of Care Testing, a domiciliary service for patients who are housebound, and the use of INRstar software for dosing advice and data reporting. Initial 3 year contract from 1 February 2018 – 31 January 2021, with the option to extend for up to a further two years. Annual contract value is £292,000
VII.2) Other additional information: Due to the level of interest in this project and the need to ensure sufficient time to identify and mobilise a provider, the start date for this contract will now be 1st February 2018.”
To view this notice, please click here:
https://www.delta-esourcing.com/delta/viewNotice.html?noticeId=274546325